Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Jun. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses        
Research and development $ 1,467 $ 1,393 $ 3,464 $ 4,718
General and administrative 952 717 3,157 1,712
Total operating expenses 2,419 2,110 6,621 6,430
Loss from operations (2,419) (2,110) (6,621) (6,430)
Other income (expense)        
Interest expense (2) (55) (1)
Gain on disposal of mortgage note receivable 106
Loss on disposal of property and equipment (61) (61)
Change in fair value of derivative liabilities 129 (148) 410 621
Total other income (expense), net 68 (150) 400 620
Loss before income taxes (2,351) (2,260) (6,221) (5,810)
Income tax benefit 483 1,459
Net loss and comprehensive loss $ (1,868) $ (2,260) $ (4,762) $ (5,810)
Net loss per common share:        
Loss per share, basic $ (0.06) $ (0.09) $ (0.17) $ (0.24)
Weighted average common shares outstanding, basic 29,923,000 24,268,000 27,360,000 24,009,000
Loss per share, fully diluted $ (0.06) $ (0.09) $ (0.17) $ (0.24)
Weighted average common shares outstanding, diluted 29,923,000 24,268,000 27,360,000 24,009,000